AstraZeneca, Sanofi, IHS, Pfizer and more to speak at EPP’s fourth annual event in Switzerland on 4 – 5 June.
Delegates from across the Pharmaceutical and MedTech industry are gearing up for the annual Life Sciences Pricing & Profit Optimisation Forum in Montreux, Switzerland.
Organised by The European Pricing Platform, in partnership with Model N and Monitor Deloitte, the forum is the only event of its kind in Europe.
Representatives from Sanofi, Ipsen, Actavis, Pfizer, Corning Life Sciences BV, IHS, Shire Pharmaceuticals and AstraZeneca are among the range of industry speakers now confirmed.
At a time of surging drug prices generating significant headlines, the programme will look at key issues currently impacting the Life Sciences industry and provide a unique chance for delegates to explore new margin erosion mitigation strategies and innovation within pharma, medical devices, biotech, and generics. It also represents an exceptional networking opportunity for delegates to discuss shared experiences and challenges.
“The growing understanding that revenue management is about more than just pricing and requires a collaborative, cross-functional approach that cannot be achieved by a single department is reflected in the spread of delegates and speakers already confirmed to attend this years’ Life Sciences Forum,” said Mark Baumgartner, vice president and general manager Europe, Model N.
“Many attendees come from outside as well as inside the pricing remit, from CFOs, finance directors, to VPs of market access/market access leads, heads of commercial and general managers. Over the course of the two days we look forward to helping participants find new ways to manage the complex issue of tender management, as well as addressing hot topics such as Global Price Management, governance and compliance.”
The EPP President added: “Model N has proven to be a valuable partner offering our audience best practices expertise in the industry. We are excited to be working with them again and look forward to stimulating discussions and interactions on next week’s Life Sciences Forum in Montreux.”
The 4th annual Model N, Monitor Deloitte and EPP Life Sciences Forum, entitled ‘Innovative in a Price Sensitive World,’ takes place at The Grand Hôtel Suisse Majestic in Montreux, 4-5 June 2014. Expert presentations and case studies over the two days will focus on key industry issues such as ‘success in the face of market complexity’; ‘who holds the key to the patients’ value chain’ and ‘profit leadership through better pricing management.’ Workshops and presentations will also cover key topics such as balancing global and regional pricing strategies; channel performance management; financial control and compliance and organisation and change management.
For more information and to book, visit: http://www.pricingevents.eu/events/4th-epp-life-sciences-forum-2014/
About European Pricing Platform (EPP)
EPP is a ‘Not-for-Profit’ knowledge exchange focused on supporting business management, pricing, and profit optimisation professionals, and CxO-level executives in Europe across a variety of industries and sectors. Our target is to update the pricing and profit optimization know-how of business managers. Our mission is to be the premier pricing expertise community for international decision makers in a wide range of industries. The interactive sharing, collecting, and development of pricing and profit optimisation knowledge are the key elements of our platform. Visit: www.pricingplatform.eu.
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximise their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies in more than 50 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
About Monitor Deloitte Pricing and Profitability Service Line
Monitor Deloitte is the strategy arm of Deloitte’s Consulting practice. Its Pricing and Profitability Management service line has more than 400 practitioners. It has provided consulting services for businesses across a wide range of industries delivering an unmatched breadth of pricing services involving strategy, human capital and technology. It has provided services to companies around the world including Eastern and Western Europe, North America, SE Asia and Latin America. Learn more on www.theproblemwithpricing.com
Tel: +44 (0)1932 895090
European Pricing Platform
Tel: +32 (0) 4722.214.171.124